Xu Li

14PUBLICATIONS
12CO-AUTHORS
Nanotoxicology, health and safetyAllergyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 15, 2026
Biologics for Children and Adolescents with Asthma: A Systematic Review and Exploratory Indirect Comparative Analysis.

|Nov 24, 2025
Safety and efficacy of stapokibart, an anti-interleukin-4 receptor α monoclonal antibody, in children aged 6-11 years with moderate-to-severe atopic dermatitis: an open-label single-arm phase Ib/IIa trial.

Mutong Zhao, Zigang Xu, Liming Wu

|Sep 29, 2025
Efficacy and Safety of Omalizumab Combined with Allergen-Specific Immunotherapy in the Treatment of Moderate-to-Severe Allergic Asthma: A Prospective Cohort Study in a Chinese Population.

Na Liu, Peng Jin, Xu Li

|Aug 27, 2025
Multi-Omics Profiling of the 42-Day Infant Gut as a Pilot Predictor of Atopic Dermatitis at One Year: A Birth Cohort Study in China.

Mutong Zhao, Xu Li, Yan Li

|May 07, 2025
Reduction in Artemisia Pollen-Specific IgE Levels During House Dust Mite Allergen Immunotherapy in Polysensitized Allergic Rhinitis Patients: A Three-Year Retrospective Study in Northern, China.

Xiaowei Sun, Xu Li, Tingting Gao

Pageof 3

Frequent Collaborators

7 joint publications

Lili Zhi

2 joint publications

Mutong Zhao

2 joint publications

Qiri Mu

2 joint publications

Peng Jin